Skip to main content
. 2021 Sep 30;49(9):0300060520980215. doi: 10.1177/0300060520980215

Figure 1.

Figure 1.

Gating strategy to identify rare CTCs. The CTCs were identified in peripheral blood samples collected before and after surgery from patients with confirmed CRC stages I to IV. The selection started in both samples with CD45− cells on CD45/SSC plots, followed by CK20+ CK7− cells (CK20/SSC and CK7/SSC plots). Next, debris and dead cells were removed using FSC/SSC and FSC-H/FSC-A plots. Finally, the potential CTC cells were identified.

CTCs, circulating tumor cells; CD45, lymphocyte common antigen; SS, side scatter; CK20, keratin 20; CK7, cytokeratin 7; APC, allophycocyanin; FITC, fluorescein isothiocyanate; PE, phycoerythrin; FS, forward scatter; H, height; A, area.